More particularly, the present invention relates to an hydroxyalkane diphosphonic compound selected from the group consisting of (A) acids having the formula ##STR7## wherein X is a member selected from the group consisting of ##STR8## and (B) a non-toxic pharmacologically acceptable water-soluble salt thereof.